Károly Schandl1,2, Dénes B Horváthy1, Attila Doros3, Ernő Majzik2, Charlotte M Schwarz1, Lajos Csönge4, Géza Abkarovits2, László Bucsi2, Zsombor Lacza5. 1. Institute of Clinical Experimental Research, Semmelweis University, Budapest, Tűzoltó u. 37-47, 1094, Hungary. 2. Saint George University Teaching Hospital of County-Fejér, Székesfehérvár, Seregélyesi u. 3., 8000, Hungary. 3. Department of Transplantation and Surgery, Semmelweis University, Budapest, Baross u. 23-26, 1082, Hungary. 4. West Hungarian Regional Tissue Bank, Petz Aladár County Hospital, Győr, Vasvári Pál u. 2-4, 9024, Hungary. 5. Institute of Clinical Experimental Research, Semmelweis University, Budapest, Tűzoltó u. 37-47, 1094, Hungary. zlacza@mac.com.
Abstract
PURPOSE: Donor site pain affects 32-43 % of patients after anterior cruciate ligament surgery when the autograft is freshly harvested bone-patellar tendon-bone tissue. Our aim was to compare functional and morphological differences between donor sites with and without serum albumin-coated bone allograft filling. METHODS: After harvesting and implanting the graft, the tibia site was filled with either fresh autologous cancellous bone enhanced with albumin-coated allograft or autologous bone alone. The patella site was filled either with albumin-coated allograft or with blood clot. Knee function was evaluated by the VISA, Lysholm and IKDC scores and a visual analog scale of pain during standing, kneeling and crouching after six weeks and six months. Computed tomography was performed at six months for morphological evaluation. RESULTS: At six weeks, both groups were still recovering from surgery and the overall knee function was still impaired but the functional scores were significantly higher in the Bone-Albumin group. The pain with crouching and kneeling was also lower as compared to controls. At six months, the knee function scores were close to normal, with a slight decrease in the controls. Pain at kneeling was still prominent in the controls, but significantly lower in the Bone-Albumin group. Computed tomography showed significantly smaller bone defects and higher bone density in the Bone-Albumin group. CONCLUSIONS: Results from the present study indicate that donor site pain, a disturbing long-term side effect of bone-patellar tendon-bone surgery, is significantly reduced if bone buildup in the patella and the tibia is augmented by serum albumin-coated bone allografts.
PURPOSE:Donor site pain affects 32-43 % of patients after anterior cruciate ligament surgery when the autograft is freshly harvested bone-patellar tendon-bone tissue. Our aim was to compare functional and morphological differences between donor sites with and without serum albumin-coated bone allograft filling. METHODS: After harvesting and implanting the graft, the tibia site was filled with either fresh autologous cancellous bone enhanced with albumin-coated allograft or autologous bone alone. The patella site was filled either with albumin-coated allograft or with blood clot. Knee function was evaluated by the VISA, Lysholm and IKDC scores and a visual analog scale of pain during standing, kneeling and crouching after six weeks and six months. Computed tomography was performed at six months for morphological evaluation. RESULTS: At six weeks, both groups were still recovering from surgery and the overall knee function was still impaired but the functional scores were significantly higher in the Bone-Albumin group. The pain with crouching and kneeling was also lower as compared to controls. At six months, the knee function scores were close to normal, with a slight decrease in the controls. Pain at kneeling was still prominent in the controls, but significantly lower in the Bone-Albumin group. Computed tomography showed significantly smaller bone defects and higher bone density in the Bone-Albumin group. CONCLUSIONS: Results from the present study indicate that donor site pain, a disturbing long-term side effect of bone-patellar tendon-bone surgery, is significantly reduced if bone buildup in the patella and the tibia is augmented by serum albumin-coated bone allografts.
Authors: Kurt P Spindler; John E Kuhn; Kevin Blake Freedman; Charles E Matthews; Robert S Dittus; Frank E Harrell Journal: Am J Sports Med Date: 2004-12 Impact factor: 6.202
Authors: Bruce D Beynnon; Robert J Johnson; Braden C Fleming; Pekka Kannus; Michael Kaplan; John Samani; Per Renström Journal: J Bone Joint Surg Am Date: 2002-09 Impact factor: 5.284
Authors: Duncan E Meuffels; Michelle T Poldervaart; Ron L Diercks; Alex W F M Fievez; Thomas W Patt; Cor P van der Hart; Eric R Hammacher; Fred van der Meer; Edwin A Goedhart; Anton F Lenssen; Sabrina B Muller-Ploeger; Margreet A Pols; Daniel B F Saris Journal: Acta Orthop Date: 2012-08-20 Impact factor: 3.717
Authors: Nathaniel A Dyment; Jennifer G Barrett; Hani A Awad; Catherine A Bautista; Albert J Banes; David L Butler Journal: J Orthop Res Date: 2020-07-01 Impact factor: 3.494
Authors: Dharmeshkumar Patel; Stephanie L Haag; Jagdish Suresh Patel; F Marty Ytreberg; Matthew T Bernards Journal: J Chem Inf Model Date: 2022-02-23 Impact factor: 4.956
Authors: Dénes B Horváthy; Károly Schandl; Charlotte M Schwarz; Károly Renner; István Hornyák; Bence T Szabó; Eugenia Niculescu-Morzsa; Stefan Nehrer; Csaba Dobó-Nagy; Attila Doros; Zsombor Lacza Journal: J Tissue Eng Regen Med Date: 2019-02-18 Impact factor: 3.963